EHT-6706 free base
EHT-6706 free base is a tubulin inhibitor with an IC50 value of 1 μM against porcine tubulin. EHT-6706 free base binds to the colchicine-binding site on tubulin to inhibit tubulin polymerization and disrupt the cellular microtubule network. EHT-6706 free base acts as an antiproliferative, vascular-disrupting, permeability-modulating, migration-inhibiting and antiangiogenic agent. EHT-6706 free base exhibits inhibitory activity against human tumor cells. EHT-6706 free base can be used in cancer and angiogenesis research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1351592-10-3
- Formule: C21H24N2O4
- Masse moléculaire:368.43
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
EHT-6706 (4 h) free base binds to the Colchicine (HY-16569)-binding site on porcine tubulin with an IC50 of 0.17 μM[1].
EHT-6706 (10 nM-50 nM; 24 h) free base disrupts the intracellular microtubule network of HCT116 cells in a concentration-dependent manner[1].
EHT-6706 (0.0003 μM-10 μM; 72 h) free base potently inhibits the proliferation of 60 human tumor cell lines (e.g., T47D, HT-29, A498, A549), with an IC50 range of 0.3 nM to 11.6 nM after 72 hours of treatment[1].
EHT-6706 (10 nM-100 nM; 18 h) free base inhibits capillary lumen formation by HUVEC on Matrigel, with an IC50 of 22 nM calculated by total lumen length and an IC50 of 15 nM calculated by the number of branching points[1].
EHT-6706 (1 nM-100 nM; overnight) free base disrupts the pre-established capillary tube structures formed by HUVEC on Matrigel[1].
EHT-6706 (10 nM-100 nM; 15 min) free base increases the permeability of confluent HUVEC monolayers in a dose-dependent manner[1].
EHT-6706 (10 nM-1 μM; 1 h) free base alters the morphology of HUVEC and disrupts the stability of the F-actin cytoskeleton, with prominent vesicular protrusions observable[1].
EHT-6706 (10 nM-100 nM; 22 h) free base inhibits FGF-2- and VEGF-induced HUVEC migration in a concentration-dependent manner, with the maximum inhibitory effect achieved after treatment with 100 nM for 22 hours[1].
EHT-6706 (40 nM; 18 h) free base causes abnormal regulation of expression levels in 3364 genes by ≥2-fold, most of which are upregulated anti-angiogenic genes, with a subset being downregulated pro-angiogenic genes, while also increasing the level of TLL-1 protein in cell supernatants[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HCT116 cells
-
Concentration:10, 25, 50 nM
-
Incubation Time:24 h
-
Result:Caused only slight microtubule and nuclear alterations at 10 nM.
Induced condensed chromatin, decreased tubulin immunoreactivity, and disordered microtubule distribution at 25 nM.
Triggered major morphological changes including loss of adhesion, cell rounding, and very weak microtubular immunoreactivity at 50 nM.
-
Cell Line:HUVEC
-
Concentration:10 nM, 100 nM, 1 μM
-
Incubation Time:1 h
-
Result:Induced cell blebbing with actin accumulation around membrane micelle-like protrusions at 100 nM.
Caused further morphological disruption at 1 μM.
-
Cell Line:HUVEC
-
Concentration:10, 50, 100 nM
-
Incubation Time:22 h
-
Result:Caused concentration-dependent inhibition of HUVEC migration toward both FGF-2 and VEGF.
Achieved near-complete inhibition at 100 nM.
Chemical Information
-
CAS No. 1351592-10-3
-
Masse moléculaire 368.43
-
Formule C21H24N2O4
-
SMILES
NC1=C(OCC)C=CC2=C1C=NC=C2CC3=CC(OC)=C(OC)C(OC)=C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Human pluripotent stem cell endothelial-cell differentiation
Human pluripotent stem cell endothelial differentiation is based on stepwise developmental patterning: early activation of WNT/GSK3β inhibition promotes mesodermal or vascular progenitor entry, followed by endothelial specification using VEGF-related signaling, BMP4, FGF2, Notch modulation, or cAMP depending on the published protocol. Endothelial differentiation is read out by acquisition of CD31, CD34, VE-cadherin/CD144, KDR/VEGFR2, vWF, Tie2, NOS3, acetylated LDL uptake, tube/network formation, barrier function, and in vivo vessel-forming capacity where tested.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Vascular/Branching Fractal Analysis
Vascular/branching fractal analysis quantifies the geometric complexity of vessel trees or vascular networks from segmented 2D images, commonly by converting vessels into binary and/or skeletonized maps and estimating fractal dimension using box-counting or related approaches. Fractal dimension is interpreted as an image-derived readout of vascular branching complexity, space filling, or density, and has been applied to retinal photographs, fluorescein angiography, OCT angiography, capillary perfusion maps, and in vitro Matrigel angiogenesis networks. The assay readout is generated from vessel-positive pixels after image preprocessing, vessel segmentation, binarization, and optional skeletonization; reported outputs include fractal dimension, vessel density, branchpoint density, endpoint density, vessel length density, tortuosity, and generation-based branching metrics when VESGEN-style analysis is used. The biological interpretation is limited to quantitative vascular patterning and s
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Endothelial Tube Formation Assay
Endothelial tube formation assay evaluates the ability of endothelial cells to attach, migrate, align, and organize into capillary-like networks when cultured on gelled basement membrane extract or Matrigel; the readout is the morphology and quantity of tube-like networks, which reflects an in vitro endothelial morphogenesis step related to angiogenesis. Basement membrane extract/Matrigel provides laminin-rich extracellular matrix cues that support endothelial differentiation into capillary-like structures, but it can contain biologically active growth factors, so growth-factor-reduced matrix is preferred when testing defined angiogenic stimulators or inhibitors.
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Endothelial Cell Migration/Angiogenic Sprouting Assay
Endothelial cell migration and angiogenic sprouting assays are in vitro (and partially ex vivo-adapted) functional models that quantify the ability of endothelial cells to undergo coordinated migration, extracellular matrix invasion, and multicellular organization into capillary-like sprouts in response to pro-angiogenic stimuli such as VEGF, bFGF, or conditioned microenvironments. These assays are used to model early angiogenic events including tip-cell formation, directional migration, and lumen-like sprout extension, which collectively reflect angiogenic activation and vascular morphogenesis processes observed in vivo.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)